NEW YORK--(BUSINESS WIRE)--New research released today by American Express Meetings & Events explores risk mitigation, including areas where lack of business controls, technology and operations around meetings and events can lead to diminished profits and fines from failure to adhere to regulatory requirements. The whitepaper specifically focuses on the Life Science vertical, including Pharmaceuticals, Biotechnology/Biological Products and Health Care Equipment & Supplies, industries wh
| < Prev | Next > |
|---|
